Due Diligence for Acquisitions

  • Overview

Our executive management team and expert consultants have conducted numerous types of due diligence assessments of pharmaceutical, biologics and biotech companies from start-ups to large, multisite companies to support acquisitions and investments. Our clients include law firms, venture capital and investment firms, industry partners and others. We have performed due diligence assessments to assess products and companies in all stages of development through to commercial production.  We can cover all aspects of regulatory compliance (regulatory strategy to cGMP and quality system compliance) and provide sound, scientifically-based advice to potential investors and purchasers.

For more information about NSF Pharma Biotech consulting in the U.S., email uspharma@nsf.org or call +1 202.822.1850.

For more information about NSF Pharma Biotech consulting in Europe, email pharmamail@nsf.org or call +44 1751 432 999.

See all related news

See all training

Pharma / Biotech Mailing List

Receive NSF pharma and biotech updates.

View Mailing List Archives

close